Premenstrual Dysphoric Disorder Clinical Trials

Find Premenstrual Dysphoric Disorder Clinical Trials Near You

Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause

Status: Enrolling_by_invitation
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: f
View:

• Assigned female at birth

• Age 18 to 45

• Naturally cycling

• Regularly occurring menstrual cycle

• Must identify as having PMS or PMDD

• Reliable ability to complete online study surveys

• Assigned female at birth.

• Age 40 to 55

• Must have newly variable menstrual cycles or report identifying as perimenopausal

• Reliable ability to complete online study surveys

Locations
United States
Texas
Texas Christian University
Fort Worth
Time Frame
Start Date: 2026-10-22
Completion Date: 2028-06
Participants
Target number of participants: 20
Treatments
Experimental: tAN treatment
For perimenopausal women: tAN administration 2 hours daily. For PMS/PMDD women: tAN administration 2 hours daily during the luteal phase.
Sponsors
Collaborators: Spark Biomedical, Inc.
Leads: Texas Christian University

This content was sourced from clinicaltrials.gov